GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Wednesday, 17th Apr 2024 ABUS stock ended at $2.78. This is 4.79% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 5.67% from a day low at $2.78 to a day high of $2.94.
90 days $2.22 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2021-02-09 $5.00 $5.14 $4.45 $4.47 6 907 862
2021-02-08 $4.29 $4.89 $4.23 $4.84 11 406 284
2021-02-05 $4.24 $4.24 $3.99 $4.15 4 191 856
2021-02-04 $3.91 $4.26 $3.86 $4.16 5 354 797
2021-02-03 $3.96 $4.02 $3.86 $3.90 1 898 361
2021-02-02 $3.97 $4.00 $3.87 $3.92 1 803 354
2021-02-01 $3.91 $4.03 $3.84 $3.88 3 825 943
2021-01-29 $3.86 $3.93 $3.63 $3.78 2 477 420
2021-01-28 $3.75 $3.78 $3.61 $3.67 2 319 427
2021-01-27 $3.74 $4.08 $3.58 $3.74 4 060 169
2021-01-26 $3.99 $4.02 $3.77 $3.82 3 058 305
2021-01-25 $4.03 $4.08 $3.84 $4.01 2 577 150
2021-01-22 $3.97 $4.12 $3.91 $4.05 1 657 047
2021-01-21 $4.11 $4.14 $3.91 $3.96 1 916 021
2021-01-20 $4.20 $4.28 $3.99 $4.11 2 331 085
2021-01-19 $3.95 $4.19 $3.78 $4.07 2 617 728
2021-01-15 $4.04 $4.11 $3.90 $3.91 2 342 520
2021-01-14 $4.10 $4.13 $3.96 $4.03 2 038 657
2021-01-13 $4.12 $4.13 $3.93 $4.04 2 214 075
2021-01-12 $4.21 $4.23 $3.97 $4.10 3 367 386
2021-01-11 $3.91 $4.49 $3.90 $4.32 5 795 928
2021-01-08 $4.04 $4.16 $3.81 $3.87 3 266 687
2021-01-07 $3.64 $4.06 $3.60 $3.90 4 905 918
2021-01-06 $3.56 $3.78 $3.51 $3.57 2 642 083
2021-01-05 $3.57 $3.67 $3.54 $3.55 1 373 310
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT